Format

Send to

Choose Destination
See comment in PubMed Commons below
Pediatrics. 2008 Apr;121(4):e975-83. doi: 10.1542/peds.2007-2081.

Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development.

Author information

1
All Children's Hospital, St Petersburg, Florida 33701, USA. dshulman@health.usf.edu

Abstract

Although treatment of children and adolescents who have disorders of growth and adolescent development with aromatase inhibitors is increasingly common, data for or against their use are extremely limited. Precocious puberty, short stature, and gynecomastia are conditions for which inhibition of the enzyme aromatase might prove beneficial to reduce clinical signs of estrogenization and/or estrogen-mediated skeletal maturation. In this report, we summarize the published data regarding the use of aromatase inhibitors in these conditions, and review known and potential benefits, safety concerns, and shortcomings of the available information.

PMID:
18381525
DOI:
10.1542/peds.2007-2081
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center